G M Bahr

1.9k citations
67 papers · 1.5k indexed · h-index 22
Topics
Mycobacterium research and diagnosis (14 papers)Tuberculosis Research and Epidemiology (13 papers)Leprosy Research and Treatment (11 papers)

In The Last Decade

G M Bahr

66 papers receiving 1.5k citations

Peers

G M Bahr
Comparison fields: 5 of 97
  • Molecular Biology 584
  • Immunology 540
  • Infectious Diseases 518
  • Epidemiology 437
  • Virology 189
Replace Pia Hartmann with:
Pia Hartmann Germany
Ε. Frederick Wheelock United States
Thuy T. Le Australia
Anna George India
A H Fortier United States
W J Morrow United States
F. Klotz France
Ralf Spallek Germany
Ana-Belén Blázquez Spain
Anuradha Chakraborti India
G M Bahr relative to Pia Hartmann Germany Pia Hartmann's profile →
Citations per field
00.5×1.5×1.8×
Pia Hartmann · 1×
Citations per year

Countries citing papers authored by G M Bahr

Since Specialization
Citations

This map shows the geographic impact of G M Bahr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G M Bahr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G M Bahr more than expected).

Fields of papers citing papers by G M Bahr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G M Bahr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G M Bahr. The network helps show where G M Bahr may publish in the future.

Co-authorship network of co-authors of G M Bahr

This figure shows the co-authorship network connecting the top 25 collaborators of G M Bahr. A scholar is included among the top collaborators of G M Bahr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G M Bahr. G M Bahr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 10
2 10
3 17
4 32
5 7
6 6
7 10
8 22
9 3
10 12
11 27
12 38
13 52
14 1
15 88
16 11
17 3
18 12
19 29
20
Use of the ELISA to screen for anti-thymocyte and anti-beta 2-microglobulin antibodies in leprosy and SLE.
42

About G M Bahr

G M Bahr is a scholar working on Virology, Immunology and Infectious Diseases, having authored 67 papers that have together received 1.5k indexed citations. Recurring topics across this work include Mycobacterium research and diagnosis (14 papers), Tuberculosis Research and Epidemiology (13 papers) and Leprosy Research and Treatment (11 papers). The work is most often cited by research in Virology (189 citations), Infectious Diseases (518 citations) and Immunology (540 citations). G M Bahr has collaborated with scholars based in Kuwait, France and United Kingdom. Frequent co-authors include G.A.W. Rook, J.L. Stanford, K. Behbehani, L Chedid, Dorian Bevec, Barbara Wolff, Michael Rühl, Herbert Jaksche, F Hammerschmid and Michèle Himmelspach. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Journal of Cell Biology and Biochemical Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026